Essex Bio-Technology (HKSE:01061) Scaled Net Operating Assets : 0.62 (As of Jun. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Essex Bio-Technology's operating assets for the quarter that ended in Jun. 2024 was HK$2,365 Mil. Essex Bio-Technology's operating liabilities for the quarter that ended in Jun. 2024 was HK$623 Mil. Essex Bio-Technology's Total Assets for the quarter that ended in Dec. 2023 was HK$2,828 Mil. Therefore, Essex Bio-Technology's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.62.

Essex Bio-Technology Scaled Net Operating Assets Historical Data

The historical data trend for Essex Bio-Technology's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essex Bio-Technology Scaled Net Operating Assets Chart

Essex Bio-Technology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.67

0.59

0.63

0.62

Essex Bio-Technology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.60	0.64	0.60	0.62	0.59

Competitive Comparison of Essex Bio-Technology's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Essex Bio-Technology's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Essex Bio-Technology's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Essex Bio-Technology Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Essex Bio-Technology's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(2312.533	-	609.759)	/	2712.397
=	0.63

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2827.558	-	515.025
=	2312.533

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	903.781	-	56.461	-	237.561
=	609.759

Essex Bio-Technology's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(2365.188	-	623.102)	/	2827.558
=	0.62

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2965.806	-	600.618
=	2365.188

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	950.326	-	87.822	-	239.402
=	623.102

Essex Bio-Technology Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Essex Bio-Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

N/A

Address

No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN

Website

http://www.essexbio.com

Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.

Executives

Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin	2101 Beneficial owner

Essex Bio-Technology Headlines

No Headlines